- Home
- SGLY vs AWH Comparison
SGLY vs AWH Comparison
Compare SGLY & AWH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGLY
- AWH
- Stock Information
- Founded
- SGLY 2001
- AWH 1993
- Country
- SGLY United States
- AWH United States
- Employees
- SGLY N/A
- AWH N/A
- Industry
- SGLY
- AWH Medical/Dental Instruments
- Sector
- SGLY
- AWH Health Care
- Exchange
- SGLY Nasdaq
- AWH Nasdaq
- Market Cap
- SGLY 5.8M
- AWH 12.8M
- IPO Year
- SGLY 2008
- AWH N/A
- Fundamental
- Price
- SGLY $1.50
- AWH $0.74
- Analyst Decision
- SGLY
- AWH Buy
- Analyst Count
- SGLY 0
- AWH 2
- Target Price
- SGLY N/A
- AWH $4.40
- AVG Volume (30 Days)
- SGLY 14.1K
- AWH 76.6K
- Earning Date
- SGLY 11-14-2024
- AWH 11-14-2024
- Dividend Yield
- SGLY N/A
- AWH N/A
- EPS Growth
- SGLY N/A
- AWH N/A
- EPS
- SGLY N/A
- AWH N/A
- Revenue
- SGLY $2,742,157.00
- AWH $8,963,000.00
- Revenue This Year
- SGLY N/A
- AWH $11.87
- Revenue Next Year
- SGLY N/A
- AWH $79.10
- P/E Ratio
- SGLY N/A
- AWH N/A
- Revenue Growth
- SGLY N/A
- AWH N/A
- 52 Week Low
- SGLY $1.27
- AWH $0.67
- 52 Week High
- SGLY $7.65
- AWH $5.65
- Technical
- Relative Strength Index (RSI)
- SGLY 42.52
- AWH 43.92
- Support Level
- SGLY $1.45
- AWH $0.71
- Resistance Level
- SGLY $1.71
- AWH $0.81
- Average True Range (ATR)
- SGLY 0.09
- AWH 0.07
- MACD
- SGLY -0.01
- AWH 0.00
- Stochastic Oscillator
- SGLY 32.35
- AWH 37.06
About SGLY Singularity Future Technology Ltd.
Singularity Future Technology Ltd is an investment holding company. The company's operating segment includes Freight Logistics Services and Sale of Crypto-mining Machines. It generates maximum revenue from the Freight Logistics Services segment. Geographically, it derives a majority of its revenue from China.
About AWH Aspira Women's Health Inc.
Aspira Womens Health Inc is engaged in developing and commercializing diagnostic tests for gynecologic diseases. Its products include OvaSuite which is a portfolio of blood tests that applies proprietary algorithms incorporating patient features; OvaWatch intended for use in assessing the risk of ovarian cancer for women with adnexal masses; and Ova1Plus is a portfolio of blood tests, Ova1Plus is a combination of two FDA-cleared tests for women with pelvic masses who are planned for surgery.